There were a few new approvals this week, plus some new FDA guidances. Here are the top regulatory stories for you to follow this week… Ironwood Pharmaceuticals announced FDA Approval of DUZALLO (Lesinurad And Allopurinol) for the treatment of hyperuricemia in patients with uncontrolled gout.  https://www.biospace.com/News/ironwood-announces-fda-approval-of-duzallo/466949/source=MoreNews Adamas Pharmaceuticals reported that the FDA has approved GOCOVRI[…]